![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Effect of Ketoconazole on the Pharmacokinetics of Doravirine (MK-1439), a Novel Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV-1 Infection
|
|
|
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV
& Hepatitis Therapy (IWCPHIVHT) - May 26-28, 2015 Washington, DC, USA
Matt S Anderson,1 Chris Chung,1 Ernestina Tetteh,1 Ka Lai Yee,1 Ying Guo,1
Li Fan,1 Scott Rasmussen,2 John A Wagner,1 Joan R Butterton1
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Celerion, Lincoln, NE, USA
![Pharm1.gif](../images/060915/060815-2/Pharm1.gif)
![Pharm2.gif](../images/060915/060815-2/Pharm2.gif)
![Pharm3.gif](../images/060915/060815-2/Pharm3.gif)
![Pharm4.gif](../images/060915/060815-2/Pharm4.gif)
![Pharm5.gif](../images/060915/060815-2/Pharm5.gif)
![Pharm6.gif](../images/060915/060815-2/Pharm6.gif)
![Pharm7.gif](../images/060915/060815-2/Pharm7.gif)
![Pharm8.gif](../images/060915/060815-2/Pharm8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|